BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 25266828)

  • 1. Decreased circulating soluble Tie2 levels in preeclampsia may result from inhibition of vascular endothelial growth factor (VEGF) signaling.
    Sung JF; Fan X; Dhal S; Dwyer BK; Jafari A; El-Sayed YY; Druzin ML; Nayak NR
    J Clin Endocrinol Metab; 2011 Jul; 96(7):E1148-52. PubMed ID: 21525162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial to: visual field after anti-vascular endothelial growth factor therapy and laser treatment for retinopathy of prematurity.
    Kozak I
    Graefes Arch Clin Exp Ophthalmol; 2023 Nov; 261(11):3049. PubMed ID: 37668740
    [No Abstract]   [Full Text] [Related]  

  • 3. Neurodevelopmental outcomes in preterm infants with retinopathy of prematurity.
    Tan H; Blasco P; Lewis T; Ostmo S; Chiang MF; Campbell JP
    Surv Ophthalmol; 2021; 66(5):877-891. PubMed ID: 33667496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased ocular blood flow after photocoagulation therapy in neonatal retinopathy of prematurity.
    Matsumoto T; Itokawa T; Shiba T; Tomita M; Hine K; Mizukaki N; Yoda H; Hori Y
    Jpn J Ophthalmol; 2017 Nov; 61(6):484-493. PubMed ID: 28932922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentrations of vascular endothelial growth factor in relation to retinopathy of prematurity.
    Hellgren G; Löfqvist C; Hård AL; Hansen-Pupp I; Gram M; Ley D; Smith LE; Hellström A
    Pediatr Res; 2016 Jan; 79(1-1):70-5. PubMed ID: 26372519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between systemic vascular endothelial growth factor and retinopathy of prematurity in premature infants: a systematic review.
    Kandasamy Y; Hartley L; Rudd D; Smith R
    Br J Ophthalmol; 2017 Jan; 101(1):21-24. PubMed ID: 27388246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity.
    Pieh C; Agostini H; Buschbeck C; Krüger M; Schulte-Mönting J; Zirrgiebel U; Drevs J; Lagrèze WA
    Br J Ophthalmol; 2008 May; 92(5):689-93. PubMed ID: 18408080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The efficiency of 810 nm diode laser photocoagulation for type1 retinopathy of prematurity].
    Chen Y; Li F; Deng X; Yin H; Liang J; Zhao M; Li X
    Zhonghua Yan Ke Za Zhi; 2015 Nov; 51(11):814-7. PubMed ID: 26850581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical role of vascular endothelial growth factor (VEGF) system in the pathogenesis of retinopathy of prematurity.
    Kwinta P; Bik-Multanowski M; Mitkowska Z; Tomasik T; Pietrzyk JJ
    Graefes Arch Clin Exp Ophthalmol; 2008 Oct; 246(10):1467-75. PubMed ID: 18546007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diode laser photocoagulation for retinopathy of prematurity: outcomes after 7 years of treatment.
    Nicoara SD; Cristian C; Irimescu I; Stefanut AC; Zaharie G
    J Pediatr Ophthalmol Strabismus; 2014; 51(1):39-45. PubMed ID: 24256550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of vascular endothelial growth factor and related factors after intravitreous bevacizumab injection for retinopathy of prematurity.
    Wu WC; Lien R; Liao PJ; Wang NK; Chen YP; Chao AN; Chen KJ; Chen TL; Hwang YS; Lai CC
    JAMA Ophthalmol; 2015 Apr; 133(4):391-7. PubMed ID: 25569026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of laser photocoagulation on plasma levels of VEGF-A, VEGFR-2, and Tie2 in infants with retinopathy of prematurity.
    Yalin Imamoglu E; Gunay M; Gursoy T; Imamoglu S; Balci Ekmekci O; Celik G; Karatekin G; Ovali F
    J AAPOS; 2014 Oct; 18(5):466-70. PubMed ID: 25266828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Solutions in Retinopathy of Prematurity.
    Moshfeghi DM
    Am J Ophthalmol; 2018 Sep; 193():xiv-xviii. PubMed ID: 29792838
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.